TWM
ABBV icon

Tripletail Wealth Management’s AbbVie ABBV Stock Holding History

Tripletail Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$673K Hold
2,579
– – 0.77% 30
2026
Q1 		$539K Sell
2,579
-20
-0.8% -$4.44K 0.73% 33
2025
Q4 		$594K Sell
2,599
-25
-1% -$5.7K 0.75% 32
2025
Q3 		$601K Hold
2,624
– – 0.71% 32
2025
Q2 		$518K Buy
+2,624
New +$488K 0.74% 31

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tripletail Wealth Management's ABBV Position: Q2 2026 in Review

Tripletail Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,579 shares worth $673K. The position accounts for 0.77% of the portfolio, ranked #30.

Tripletail Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tripletail Wealth Management held 2,579 shares of AbbVie worth $673K as of Q2 2026.
  • Tripletail Wealth Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.77% of Tripletail Wealth Management's portfolio in Q2 2026, its #30 holding.
  • Tripletail Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tripletail Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.